Elite Pharmaceuticals, Inc.
ELTP
$0.40
-$0.021-4.99%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.21% | 13.65% | 18.31% | 22.18% | -32.79% |
| Total Receivables | -13.94% | 4.67% | 5.31% | 21.51% | 52.54% |
| Inventory | 42.31% | 2.41% | 6.97% | -9.73% | -5.91% |
| Prepaid Expenses | 777.84% | -70.07% | -16.88% | -47.87% | 182.79% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 6.08% | 4.94% | 7.86% | 7.69% | 6.99% |
|
|
|||||
| Total Current Assets | 6.08% | 4.94% | 7.86% | 7.69% | 6.99% |
| Net Property, Plant & Equipment | -2.88% | -3.34% | 1.09% | 38.75% | 7.75% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.75% | -4.35% | 3.09% | 7.56% | 3.05% |
| Total Assets | 2.90% | 0.40% | 5.01% | 11.99% | 5.62% |
|
|
|||||
| Total Accounts Payable | 194.48% | -23.92% | -3.95% | -6.10% | -19.90% |
| Total Accrued Expenses | -41.07% | -4.46% | 14.80% | -59.47% | 6.51% |
| Short-term Debt | 2.50% | 0.00% | 0.00% | 0.00% | 0.00% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -2.96% | -0.98% | 14.29% | 175.71% | 24.49% |
| Total Finance Division Other Current Liabilities | 18.86% | -39.21% | 42.85% | 3,649.62% | 0.00% |
| Total Other Current Liabilities | 18.86% | -39.21% | 42.85% | 3,649.62% | 0.00% |
| Total Current Liabilities | 14.28% | -8.28% | 7.39% | -31.89% | 0.42% |
|
|
|||||
| Total Current Liabilities | 14.28% | -8.28% | 7.39% | -31.89% | 0.42% |
| Long-Term Debt | -0.77% | -5.19% | -1.07% | -1.12% | -1.14% |
| Short-term Debt | 2.50% | 0.00% | 0.00% | 0.00% | 0.00% |
| Capital Leases | -5.08% | -2.68% | -5.38% | 1,611.15% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 53.72% | 140.40% | 44.09% | 12.44% | 75.65% |
| Total Liabilities | 32.69% | 38.30% | 13.52% | -7.82% | 10.37% |
|
|
|||||
| Common Stock & APIC | 0.04% | 0.03% | 0.03% | 4.71% | 0.37% |
| Retained Earnings | -8.59% | -9.53% | 0.53% | 2.78% | 0.59% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -22.89% | -18.86% | 1.16% | 24.06% | 2.93% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -22.89% | -18.86% | 1.16% | 24.06% | 2.93% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -22.89% | -18.86% | 1.16% | 24.06% | 2.93% |
|
|
|||||